A four-year evaluation of mobile addiction services across Massachusetts found the model reached 4,645 adults and started 1,227 of them on buprenorphine, a medication for opioid use disorder.
What the Study Measured
Researchers co-led by Mass General Brigham tracked six mobile programs operating across Massachusetts between January 1, 2022 and June 30, 2024. Their findings appear in the International Journal of Environmental Research and Public Health.
Over that window the programs logged 16,117 clinical encounters serving 4,645 individuals, along with 17,887 harm reduction encounters aimed at reducing the health, social, and legal consequences of drug use.
The model began in 2018 as a single Boston clinic under the Kraft Center for Community Health’s Community Care in Reach program.
It has since grown to six programs statewide with support from the Massachusetts Department of Public Health and the Kraft Center. The programs focus on people at high risk of drug-related illness and death who are unhoused or at risk of losing housing.
Medication Access Was a Central Outcome
Buprenorphine was initiated among 1,227 people during the study period. Of those, 15% were still in buprenorphine-based treatment at 180 days.
Buprenorphine is a partial opioid agonist used in medication-assisted treatment, often shortened to MAT. It reduces cravings and withdrawal symptoms without producing the intensity of a full agonist, and it is one of three FDA-approved medications for opioid use disorder alongside methadone and naltrexone.
Six-month retention is a standard benchmark in opioid treatment research. The 15% figure reflects a population the authors describe as disconnected from conventional care.
Why the Delivery Model Matters
Senior author Elsie M. Taveras, MD, MPH, chief community health and health equity officer at Mass General Brigham, said the model proved adaptable across regions and that street-based mobile services can be operated by different kinds of organizations, from academic medical systems to community health centers.
Cynthia A. Tschampl, PhD, a senior research scientist at the Heller School at Brandeis University, said the physical presence of mobile units offers a low-barrier access point for adults with complex needs.
The researchers identified challenges across the programs, but reported that all of them were able to engage hard-to-reach individuals.
What This Means for Treatment Seekers
Mobile programs are an entry point rather than a replacement for the full continuum of care. For many people the next step is still an inpatient or outpatient program.
If transportation, housing instability, or a poor prior experience with a clinic has stalled a search for addiction treatment, it is worth asking whether a mobile or street outreach team operates in your area. Many are run by community health centers rather than hospitals.
It is also worth asking any program whether it can prescribe buprenorphine or other MAT medications directly or whether it refers out. Continuity between first contact and ongoing care is where this model showed its limits.
Finding the Right Rehab
Comparing rehab centers on a few specific points makes the search shorter:
- Ask whether a program can start medication-assisted treatment at the first visit rather than after a waiting period.
- Confirm which levels of care are offered on site and what happens at the handoff between them.
- Verify state licensing and accreditation before committing.
- Check insurance coverage for addiction treatment, including whether the program accepts Medicaid.
Rehab.com’s directory lists verified treatment centers nationwide, searchable by location, level of care, and insurance accepted. Call
800-985-8516
( 
Sponsored Helpline )
to learn more information about rehab facilities in your area.
